Stocksigma LogoStocksigma Logo

Accretion Pharmaceuticals Alters Memorandum of Association Object Clause Following Shareholder Approval

Accretion Pharmaceuticals Limited received shareholder approval via postal ballot on 9th Oct'26 to alter Clause III (Object Clause) of its Memorandum of

Accretion Pharmaceuticals Alters Memorandum of Association Object Clause Following Shareholder Approval

Accretion Pharmaceuticals Ltd 路 Others (Uncategorized) 路 11 Oct 2026, 12:23 am

Accretion Pharmaceuticals Alters Memorandum of Association Object Clause Following Shareholder Approval Accretion Pharmaceuticals Limited received shareholder approval via postal ballot on 9th Oct'26 to alter Clause III (Object Clause) of its Memorandum of Association. The approved amendment substitutes Main Object Clause III(A) and inserts new sub-clauses numbered III(B)(10) through III(B)(47). The expanded mandate broadly covers manufacturing, trading, research, and distribution across pharmaceuticals, nutraceuticals, medical devices, healthcare facilities, diagnostic centers, clinical research organizations, consumer food items, and global strategic investments.

Original exchange filing (PDF)

More announcements from Accretion Pharmaceuticals Ltd

All Accretion Pharmaceuticals Ltd announcements